sp
ki
monotherapy
proven
trans
email
taken
implementation
london
512
potentially
mies
materials
medicine
shown
threshold
trust
previous
consistently
grais
reduce
mefloquine
access
heterogeneities
eyles
contributions
res
malar
address
presence
setting
thank
sustaining
type
transmissible
project
estimate
smith
share
2002
jo
endorsed
there
uncertainties
bredenkamp
explored
patent
686
thailand
appropriate
medi
rate
western
tables
montgomery
stepwise
246
south
density
anisms
nentially
sensitivity
people
provides
536
top
identify
treated
protection
acquisition
falciparum
pukrittayakamee
readily
mosquito
info
klein
varying
directly
allowing
arising
vari
dis
tual
cartwright
ali
nated
few
s3
param
palmer
phaipun
authors
reducing
win
phares
nd
delaying
308
price
researc
even
ltd
affecting
contact
african
keppel
1991
immediately
should
301
elimi
acceptance
parum
ance
dj
artemether
calculated
larities
selected
stochastic
keep
precious
yours
obstacle
poor
chemoprophylactic
therapies
resulting
schellenberg
349
sci
already
treatments
clinical
lagog
describing
properly
subsequent
pb
inform
coefficient
multidrug
proposed
attractive
etc
drugs
doc
approximately
reproductive
doubts
dondorp
obonyo
lowe
545
switching
affordability
additional
262
vivo
person
varies
bc
biomedical
subsidy
e330
table
progresses
line
regressions
propor
exposure
result
partner
martensson
asympto
delay
biology
substantial
spatio
burden
references
disadvantage
set
real
tial
humoral
need
353
esti
white
quantitatively
could
does
rates
per
bednet
influences
susceptible
fewer
process
yeung
cv
research
anopheline
eliminated
freeman
sion
ja
dow
facilitate
protected
pyrogenic
arisen
sensitive
driven
781
difficult
s8
saturation
both
disseminating
ments
licensee
sidies
overcome
eventually
scenarios
although
important
presents
vaccine
trop
prior
mainly
all
tempered
eled
2006
considera
would
omumbo
development
antifolate
whitmire
deploy
submit
insecticides
factor
parasite
qinghaosu
including
control
sue
global
consistency
koech
simulation
unless
created
mj
portion
1957
554
content
malaria
sy
artemisinin
sibley
gains
govern
kenya
wrote
durrheim
solely
structured
mw
strains
1976
create
below
intensities
jones
229
multiple
mod
cases
sim
rosenthal
elsewhere
kp
equally
absence
methods
recently
duration
grateful
kachur
formulating
rather
exposures
shortening
age
pembroke
cure
sexual
decreasing
terization
classes
higher
sm
472
distributed
results
sus
key
meek
antimalarial
matching
dk
cre
pharmacokinetic
likelihood
relative
1186
dynamic
attribution
details
open
significant
529
derive
extended
area
hope
importation
equation
forms
argument
itn
establishment
modelling
mahosot
expo
piperaquine
predict
pital
chemother
comes
chumo
kumar
measures
efficacious
four
they
zation
protracted
parameterization
selective
superinfec
cvs
popula
white1
micro
individual
entire
who
aj
ranford
parassitologia
weak
phd
according
symp
simple
mthembu
14216
cycle
bloland
differentiation
malariatherapy
synergizes
options
predicted
505
spreads
filter
staff
increases
carrying
je
ini
arises
failure
factors
plos
expected
biomass
main
1998
pre
quantifying
influx
studies
105
acade
advice
substantially
esa
effects
suggestions
chloroquine
many
papua
refuge
molyneux
reasonably
entomologic
edited
life
tested
erage
forster
toms
dlamini
system
activities
author
fraction
uncertain
widespread
entomological
act
1654
infectiousness
every
provide
yeung1
cine
recovery
bly
model
comments
national
policy
addition
hypercube
tocyte
risk
vectorial
implications
1974
care
addressed
s2
understanding
imported
dynamics
kj
webster
identified
367
luxemburger
permits
focused
rank
highly
shows
slow
685
gupta
similarly
aic
on
focusing
cr
patient
measured
presented
benefit
study
outset
chemotherapy
looareesu
populations
mosquitoes
declines
outcomes
gmail
kemri
natal
kasia
case
implemented
places
untreated
alone
little
switch
combination
faster
about
down
1258
models
120
defined
questions
parameter
inappropriate
relation
md
combina
uncertainty
complexity
beyond
suphajaisiddhi
together
original
increase
tives
soc
infectivity
stabilizing
ramsan
technical
200
providing
suggested
own
buying
doi
2001
published
4centre
ting
improved
migrants
wan
possible
widely
later
kept
costly
bekessy
derivative
climatic
sampling
tially
length
1400
allen
varied
containing
1388
eradication
understand
incorporation
ey
obiero
past
fractional
cost
biological
ric
introduced
224
rotllant
impact
formulation
run
sirichaisinthop
smru
severity
reservoir
predictive
excluding
features
under
answer
contrast
hygiene
prevalence
molecular
biting
our
its
currently
determined
observations
med
deploying
fk
added
frame
ineffective
pyrimethamine
distributions
remains
group
ch
pronounced
leverhulme
provided
variations
accepted
relatively
ation
bed
sattabongkot
hk
immu
end
treatment
respective
nation
vc
reach
hastings3
funded
great
commons
supplementary
particular
hyg
kwazulu
formalism
without
determine
than
fever
force
initial
become
invaluable
effective
department
ent
central
fit
reduction
in3
tion
borders
ciparum
jackson
follow
continued
several
rapid
longitudinal
chil
2000
katabira
gerstenmaier
ecological
resistance
varia
thesis
baseline
fitted
jeffery
order
bio
arrow
gam
data
prevailing
tect
stable
treat
scenario
corresponding
after
355
discussion
as
quantitative
khatib
2005
paiphun
bhattarai
exponentially
lamola
slowed
second
sulphadoxine
versus
s7
1997
span
variables
protect
eliminate
vitro
sustainable
assessment
programmed
kamya
work
strongly
attacks
mahidol
latin
ian
gametocytaemia
tolerance
pongtavornpinyo
new
roberts
paru
influen
org
emerged
whether
pro
reviewed
guidance
three
needed
simulations
develop
stepniewska
vaccinology
lond
eters
affordable
settings
ily
ally
was
prediction
mathematical
boni
thanks
two
conclusion
tropmedres
wide
1393
each
cited
923
africa
njw
senegal
your
14221
controlling
role
gelband
uge
isinin
holoendemic
exploring
variable
assess
sympto
technique
consequences
actual
unaltered
624
economics
evolve
gsr
1990
proportional
tropical
countries
1709
suggests
generally
full
describe
deployment
prcc
molineaux
613
half
realistic
121
handles
available
consistent
mehta
873
probability
infrastructures
however
testing
acquired
patients
compared
predictors
consequently
nuffield
1334
output
one
valuable
oraganization
combinations
mission
relationship
extensive
predicts
committing
ten
recrudescences
incorporated
estimated
decision
any
1422
allowed
site
hos
more
material
year
cross
subjects
1047
usa
patterns
fo
141
facets
laboratory
simulates
eliminating
mono
intellec
among
considered
class
operational
most
bomu
usage
migration
firmed
information
nested
philos
882
proportion
s10
matic
bination
private
abbreviations
hastings
cs
asexual
relevant
objective
still
cover
incentives
will
much
infected
storey
part
nets
compound
parasitaemia
hyper
average
hosts
lifetime
coefficients
constitute
drug
upon
only
very
218
infection
correlation
walmsley
chong
nario
160
walker
component
lc
packer
nosten
analyses
biomed
thereby
immunity
publishing_adv
410
weber
ref
strong
malized
ih
sustained
fal
malarial
balanced
empirical
into
gm
good
indeed
making
demand
chotivanich
journal
dependent
ratio
till
aw
provision
west
then
markers
coverage
tdr
novo
stays
max
ettling
raimond
state
zanzibar
381
pd
de
associated
ngumbao
decreases
oster
pinder
blood
cambodia
uganda
antimicrob
increasing
outputs
wm
trape
recrudescence
come
file
dielmo
ci
formula
less
tremendous
parasitology
1993
due
horizon
argued
percentage
analysis
chongsuphajaisiddhi
introduction
tall
fixed
laxminarayan
paper
received
monotherapies
dv
kampala
uniform
often
unrelated
intensity
creativecommons
implied
nahlen
519
thus
similar
333
1995
value
liverpool
antia
macdonald
biomedcentral
changes
areas
described
3liverpool
relationships
same
slower
science
free
mr
situations
anti
make
assuming
license
timing
maintaining
explanation
evolution
epidemiology
allow
sen
parame
input
gametocytocidal
commenges
scholarship
tool
sent
sector
chantra
arjen
adults
applied
some
ap
here
function
mitsanze
lancet
beadle
unrestricted
slowing
sitemia
ver
abdulla
raised
constant
heterologous
spread
ones
expressed
non
against
given
ensure
yet
certainly
plays
failing
chain
obstacles
bangkok
benefits
needs
focus
ad
article
adherence
ability
simi
link
dotted
ndeezi
between
ous
lives
likely
peer
func
sce
controls
emerges
vector
fail
163
artem
lation
attack
steady
guinea
347
endemic
levels
koella
variation
bjorkman
intermittent
dose
com
trial
1329
modeling
ronmental
primaquine
dramatic
465
updates
onyango
likelihoods
bathet
140
creative
www
385
looked
ant
id990985
am
public
homologous
saving
parasitol
influential
1378
1054
kenyan
619
eastern
diseases
cn
eradicated
children
day
e309
rogier
240
230
115
agents
lower
must
specific
parasites
insecticide
cov
design
scientist
characteristics
214
lit
ter
illness
1650
geneva
using
hayes
eir
becomes
marsh
thieren
unpp
advantage
components
bining
endemicity
1996
et
formulated
concentrations
ricci
ing
infect
fitness
pj
other
significance
licenses
269
normally
newton
oxford
university
treatmentguidelines2006
temporal
beier
gauge
encouraging
literature
britain's
wellcome
babirye
always
bitten
s1
2008
normalized
properties
ship
prr
nickw
clinically
nj
auc
limited
manuscript
rap
policies
presumptive
powerful
ann
ther
plasmodium
easier
species
organ
within
obtained
mh
mafazy
morbidity
proc
chloroqine
im3
curve
guide
washington
stratified
persuasively
traded
artemisinins
peshu
pathways
2004
poorest
partial
nickd
symptomatology
envi
choice
vaccines
response
repeatedly
increasingly
well
357
preventing
because
dorsey
depends
potential
engl
sharp
70s
sources
level
mayxay
resistant
smaller
bull
linked
faculty
173
acts
implementing
uk
frequency
approaching
suitable
infections
barnes
wp
ulation
weakness
dt
fixation
world
guidelines
transmis
risks
slightly
quantifica
early
savannah
390
lisa
1955
jf
vary
para
pv
kleinschmidt
survival
docs
unique
jamison
indicates
bite
used
delays
figure
wirichada
users
true
unresolved
constructed
mated
nor
press
plicity
costs
when
various
background
1mahidol
predicting
reached
pubmed
tracked
coast
incidence
copyright
remote
july
http
lifespan
1999
pdf
may
re
acad
incorporating
archived
different
789
miological
emergence
hype
ii
terms
mid
apy
host
communities
mismatched
1992
further
sg
change
organi
summarized
infec
november
int
number
developing
randomly
organization
influence
lumefantrine
institute
zheng
nity
prolong
initially
now
mathematicall
population
test
step
resist
100
how
continu
their
comprehensive
best
hoffman
nurse
therefore
slowly
asymptomatic
capacity
question
point
ial
assumed
pressure
elimination
s6
far
required
flow
makes
rw
also
avoiding
000
distribution
related
functions
specified
cancer
translate
adjust
but
too
expectation
therapeutic
biol
small
over
reaching
found
largely
deriva
schematic
antimalaria
criterion
sendagire
prevent
click
epidemiological
migrant
game
exposed
statistical
like
vides
mitted
citation
repeated
mating
receive
parameters
achieving
aucgam
especially
include
develops
training
papers
low
evidence
jc
tsoka
2875
rn
easy
through
realized
while
tle
theoretical
256
influenc
paul
allows
take
sitive
craig
worldwide
peaks
sir
prevents
based
918
molteni
1413
developed
purposes
mf
illustrates
extrapolation
ures
linear
residual
imum
school
simplified
karen
depend
im1
1994
finally
unit
transmissibility
circumstances
made
page
tions
ss
read
robustness
cube
once
nicholas
sueur
estimation
febrile
greater
such
shape
day1
150
degree
245
abbas
jn
current
example
epide
discussed
chisengwa
present
sherwood
mech
see
choices
north
recommends
susceptibility
robustly
combining
2health
bjornstad
oloo
adjusting
zhou
ate
gametocyte
specifying
time
baird
evaluate
ment
combi
intellectual
either
health
governed
son
human
driving
review
framework
duce
clemens
diagram
values
ab
kaneko
1658
ceived
general
maximum
kuile
complex
century
iterative
agreed
mechanisms
dren
watkins
ultimate
270
artesunate
has
2007
dominant
al
modified
fitting
thereafter
macro
falls
achieve
stage
consist
inoculation
size
estimates
production
t50
maciej
slows
days
publish
olson
bales
rebecca
assist
693
street
useful
immigrants
strategies
meas
acting
im
popu
dl
completely
sufficiently
trends
identifying
use
518
singer
until
bl
majority
capacities
pharmacodynamic
ak
prices
staedke
therapy
pan
con
1966
perkins
poorer
existing
rj
humans
infective
vectors
aim
vivax
charge
dondorp1
dn
eventu
transmitting
acta
origins
whilst
essential
cui
contribution
safe
asp
dietz
momentum
corre
172
establish
consists
pointed
observed
420
prccs
stages
sl
us
interventions
highest
lhs
established
malariajournal
jk
mean
immune
ceptibility
reproduction
cannot
mcelroy
not
edstein
surveillance
enthusiasm
years
1475
akaike
effectiveness
involves
fontanet
remain
derivatives
medium
selection
133
yan
newbold
severe
particularly
effect
transmission
reduced
stay
tolerated
s9
pop
times
jd
lee
search
formulations
community
cisse
166
recrudescent
represents
selec
gives
vented
persons
im2
shunmay
jr
abstract
major
natl
primary
place
thomas
acknowledgements
high
availability
falci
demonstrated
idly
combined
first
snow
overall
sub
repre
structure
symptomatic
2003